Literature DB >> 25445440

Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.

Se-Chan Kim1, Shuijing Wu2, Xiangming Fang3, Jens Neumann4, Lars Eichhorn4, Grigorij Schleifer4, Olaf Boehm4, Rainer Meyer5, Stilla Frede4, Andreas Hoeft4, Georg Baumgarten4, Pascal Knuefermann4.   

Abstract

AIMS: Toll-like receptor (TLR)9 ligand CpG-oligodeoxynucleotide (CpG-ODN) exerts preconditioning in myocardial ischemia/reperfusion. We hypothesized a postconditioning effect of CpG-ODN in a murine closed-chest model of myocardial infarction.
MATERIALS AND METHODS: C57BL/6 (12 weeks, male, WT) mice were instrumented at the left anterior descending artery, then allowed 5d of recovery before 30 min ischemia. Treatments comprised: 1) PBS: 250 μl phosphate buffer solution intraperitoneally 5 min before reperfusion and 2) IPC (ischemic postconditioning): 3 twenty-second reperfusion and occlusion episodes at the end of ischemia 3) CpG-ODN: 1668 thioate 0.2 μmol/kg BW intraperitoneally 5 min before reperfusion. Infarct size was assessed via triphenyltetrazolium chloride (TTC) staining after 2 and 24h reperfusion. Myocardial mRNA-expression of cytokines was measured using real-time PCR after 2h reperfusion. Phosphatidylinositol-3 kinase (PI3K)-inhibitor wortmannin was injected intraperitoneally in WT 15 min before postconditioning and PBS in each group. Cardiac function in WT was assessed with a left-ventricular pressure-volume catheter at 24h reperfusion. KEY
FINDINGS: Following 30 min ischemia and 2h reperfusion, infarct size was diminished by 90% in WT postconditioned with CpG-ODN (2.4 ± 1.55 IS/AAR%) and IPC (1.98 ± 1.03 IS/AAR%) compared to PBS mice (23.2 ± 3.97 IS/AAR%). Infarct size increased following 24h reperfusion but the differences remained robust. Expression of TNF-α and IL-10 was increased in CpG-ODN. Wortmannin abolished the postconditioning effect of CpG-ODN and IPC. Ejection fraction and preload-recruitable stroke work were significantly greater in CpG-ODN mice. SIGNIFICANCE: CpG-ODN confers postconditioning via activation of TLR9. Cardiac function is preserved following CpG-ODN postconditioning. The PI3K -inhibitor wortmannin attenuates CpG-ODN postconditioning.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Toll-like receptor; cytokines; innate immunity; myocardial infarction; postconditioning

Mesh:

Substances:

Year:  2014        PMID: 25445440     DOI: 10.1016/j.lfs.2014.09.029

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.

Authors:  Allison B Goldfine; Steven E Shoelson
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice.

Authors:  Alexander O Krogmann; Enzo Lüsebrink; Martin Steinmetz; Tobias Asdonk; Catharina Lahrmann; Dieter Lütjohann; Georg Nickenig; Sebastian Zimmer
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

3.  Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury.

Authors:  Tobias Hilbert; Paul Markowski; Stilla Frede; Olaf Boehm; Pascal Knuefermann; Georg Baumgarten; Andreas Hoeft; Sven Klaschik
Journal:  J Cell Mol Med       Date:  2018-04-19       Impact factor: 5.310

4.  Macrophage-Derived Exosomes in TLR9-/- Mice Ameliorate Sepsis-Induced Mitochondrial Oxidative Stress and Apoptosis in Cardiomyocytes.

Authors:  Xiang Li; Junyu Luo; Yanmei Li; Lu Jia; Yuejin Li; Shili Ye; Lanlan Liu; Yanxuan Yu; Yonggang Lu; Yunpeng Luan
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

5.  DHA Supplementation Attenuates MI-Induced LV Matrix Remodeling and Dysfunction in Mice.

Authors:  I Habicht; G Mohsen; L Eichhorn; S Frede; C Weisheit; T Hilbert; H Treede; E Güresir; O Dewald; G D Duerr; M Velten
Journal:  Oxid Med Cell Longev       Date:  2020-05-14       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.